Market Overview:
The global flucytosine tablets market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising demand for generic drugs, and growing awareness about cancer treatments. The global flucytosine tablets market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 50mg/pcs and 25mg/pcs. On the basis of application, the market is segmented into colon cancer, rectal cancer, gastric cancer, breast cancer, ovarian cancer and others. The North America region dominates this market followed by Europe due to early adoption of novel technologies in these regions coupled with rising incidence rates for various types cancers such as colorectal cancers which are treated using flucytosine tablets globally.
Product Definition:
Flucytosine Tablets is a synthetic antifungal agent that is used to treat fungal infections. It works by inhibiting the growth of the fungus.
50mg/pcs:
50mg/pcs is used for the treatment of acute bacterial skin and soft tissue infections. It's a type of antibiotics drug that works by killing bacteria. Flucytosine is an antibiotic, which is commonly prescribed to treat skin infections including cellulitis, impetigo, keratinization disorders (eczema), and staphylococcal scalded skin syndrome among others.
25mg/pcs:
25mg/pcs is used for the treatment of acute lymphoblastic leukemia and it's usage in flucytosine tablets market is growing at a significant rate. It was first synthesized by Drs.
Application Insights:
Colon cancer accounted for the largest share in terms of application and is expected to witness a lucrative CAGR during the forecast period. Flucytosine tablets are used as an anti-cancer drug for treatment of advanced colon and rectal cancers. The drug exhibits high efficacy against tumor cells with minimal toxicity towards normal tissues. This property has led to its extensive use in chemotherapy of various advanced cancers, including colon, breast, lung, prostate & ureter cancer.
Flucytosine is also used as a chemotherapeutic agent in the treatment of gastric adenocarcinoma and other related malignant tumors with high effectiveness than 5-fluorouracil (5-FU). It has been approved by U.
Regional Analysis:
North America was the largest regional market in 2017 owing to high product demand. The region is expected to maintain its dominance throughout the forecast period due to increasing incidence rates of cancer and favorable reimbursement policies for oncological treatment in U.S., Canada, and Mexico.
Growth Factors:
- Increasing incidence of fungal infections: The increasing incidence of fungal infections is one of the key growth drivers for Flucytosine Tablets market. Fungal infections are caused by a group of microorganisms, which include yeasts and molds. These organisms can cause serious health problems in humans, including skin and nail infection, pneumonia, meningitis and blood stream infection. According to the Centers for Disease Control and Prevention (CDC), around 6 million people in the U.S are affected by fungal infections every year and these numbers are rising due to various factors such as increase in population size, aging population etc. This is expected to drive the demand for Flucytosine Tablets market over the forecast period
- Rising prevalence of resistant strains: The rising prevalence of resistant strains is another major growth driver for Flucytosine Tablets market. Fungal resistance to flucytosine has been reported from various parts of world including Europe, North America and Asia Pacific region .This has led to increased use fluconazole as an alternative treatment option which is expected to hamper the sales prospects for Flucytosine tablets over the forecast period . However ,the increasing awareness about antifungal resistance among physicians would help create new opportunities for this market during forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Flucytosine Tablets Market Research Report
By Type
50mg/pcs, 25mg/pcs
By Application
Colon Cancer, Rectal Cancer, Gastric Cancer, Breast Cancer, Ovarian Cancer, Others
By Companies
Ancobon Caps, JOLLY HEALTH CARE
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Flucytosine Tablets Market Report Segments:
The global Flucytosine Tablets market is segmented on the basis of:
Types
50mg/pcs, 25mg/pcs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Colon Cancer, Rectal Cancer, Gastric Cancer, Breast Cancer, Ovarian Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ancobon Caps
- JOLLY HEALTH CARE
Highlights of The Flucytosine Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 50mg/pcs
- 25mg/pcs
- By Application:
- Colon Cancer
- Rectal Cancer
- Gastric Cancer
- Breast Cancer
- Ovarian Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Flucytosine Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Flucytosine tablets are a medication used to treat cancer. Flucytosine is an anticancer drug that works by stopping the growth of cancer cells. Flucytosine tablets are taken by mouth usually once a day.
Some of the major players in the flucytosine tablets market are Ancobon Caps, JOLLY HEALTH CARE.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Flucytosine Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Flucytosine Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Flucytosine Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Flucytosine Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Flucytosine Tablets Market Size & Forecast, 2020-2028
4.5.1 Flucytosine Tablets Market Size and Y-o-Y Growth
4.5.2 Flucytosine Tablets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 50mg/pcs
5.2.2 25mg/pcs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Colon Cancer
6.2.2 Rectal Cancer
6.2.3 Gastric Cancer
6.2.4 Breast Cancer
6.2.5 Ovarian Cancer
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Flucytosine Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Flucytosine Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 50mg/pcs
9.6.2 25mg/pcs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Colon Cancer
9.10.2 Rectal Cancer
9.10.3 Gastric Cancer
9.10.4 Breast Cancer
9.10.5 Ovarian Cancer
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 50mg/pcs
10.6.2 25mg/pcs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Colon Cancer
10.10.2 Rectal Cancer
10.10.3 Gastric Cancer
10.10.4 Breast Cancer
10.10.5 Ovarian Cancer
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 50mg/pcs
11.6.2 25mg/pcs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Colon Cancer
11.10.2 Rectal Cancer
11.10.3 Gastric Cancer
11.10.4 Breast Cancer
11.10.5 Ovarian Cancer
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 50mg/pcs
12.6.2 25mg/pcs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Colon Cancer
12.10.2 Rectal Cancer
12.10.3 Gastric Cancer
12.10.4 Breast Cancer
12.10.5 Ovarian Cancer
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 50mg/pcs
13.6.2 25mg/pcs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Colon Cancer
13.10.2 Rectal Cancer
13.10.3 Gastric Cancer
13.10.4 Breast Cancer
13.10.5 Ovarian Cancer
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Flucytosine Tablets Market: Competitive Dashboard
14.2 Global Flucytosine Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ancobon Caps
14.3.2 JOLLY HEALTH CARE
